KEVIN P STARR
CIK 1192603 · last filed 2023-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$470.01M
Companies
17
Total Filings
80
Lifetime Open-Market Net
-$119.26M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Sage Therapeutics, Inc. (SAGE) Delisted | Director | 320,659 | $8.68 | $2.78M | -$35.52M | 24 | 2023-06-16 |
| Jounce Therapeutics, Inc. (JNCE) Delisted | 10%+ Owner | 3,265,434 | $1.88 | $6.14M | $0 | 1 | 2021-06-14 |
| NRIX | 10%+ Owner | 4,553,898 | $16.95 | $77.19M | $0 | 1 | 2021-02-08 |
| RVMD | 10%+ Owner | 1,909,317 | $153.87 | $293.79M | $0 | 1 | 2020-02-18 |
| Neon Therapeutics, Inc. (NTGN) Delisted | 10%+ Owner | 9,741,636 | — | — | $0 | 1 | 2018-07-03 |
| MyoKardia, Inc. (MYOK) Delisted | Director | 1,109,848 | — | — | -$71.43M | 12 | 2018-03-07 |
| Allena Pharmaceuticals, Inc. (ALNA) Delisted | 10%+ Owner | 2,575,964 | $0.07 | $193.2K | $15.05M | 1 | 2017-11-06 |
| Global Blood Therapeutics, Inc. (GBT) Delisted | Director | 1,563,693 | $68.49 | $107.10M | -$1.74M | 5 | 2017-06-16 |
| ALNY | Director | 25,000 | $282.85 | $7.07M | -$16.06M | 14 | 2017-06-06 |
| CTMX | 10%+ Owner | 5,201,767 | $3.01 | $15.66M | -$463.8K | 3 | 2017-04-14 |
| Blueprint Medicines Corp (BPMC) Delisted | 10%+ Owner | 5,453,753 | $129.46 | $706.04M | -$3.00M | 3 | 2016-12-21 |
| EDIT | 10%+ Owner | 3,906,176 | $2.50 | $9.77M | -$93.7K | 1 | 2016-09-07 |
| VYGR | 10%+ Owner | 11,061,176 | $3.50 | $38.71M | $0 | 1 | 2015-11-18 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Director | 846,493 | — | — | -$6.00M | 6 | 2015-09-25 |
| Foundation Medicine, Inc. (FMI) Delisted | 10%+ Owner | 0 | — | — | $0 | 1 | 2015-05-15 |
| AGIO | Director | 944,581 | $29.46 | $27.83M | $0 | 3 | 2015-02-19 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Director | 695 | — | — | $0 | 2 | 2007-07-12 |
Recent Filings · Page 3 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-09-27 | MyoKardia, Inc. (MYOK) Delisted | Sell (S) | −601,400 | -$25.86M | EDGAR |
| 2017-09-27 | Sage Therapeutics, Inc. (SAGE) Delisted | Other (J) | −545,000 | $0 | EDGAR |
| 2017-09-12 | MyoKardia, Inc. (MYOK) Delisted | Sell (S) | −201,250 | -$8.25M | EDGAR |
| 2017-07-19 | Sage Therapeutics, Inc. (SAGE) Delisted | Other (J) | −800,000 | $0 | EDGAR |
| 2017-06-16 | Global Blood Therapeutics, Inc. (GBT) Delisted | Other (J) | −6,000,000 | $0 | EDGAR |
| 2017-06-16 | MyoKardia, Inc. (MYOK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-09 | Sage Therapeutics, Inc. (SAGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-06-06 | ALNY | Grant (A) | — | $0 | EDGAR |
| 2017-05-19 | Global Blood Therapeutics, Inc. (GBT) Delisted | Mixed | −6,310,248 | $0 | EDGAR |
| 2017-04-14 | CTMX | Sell (S) | −28,357 | -$463.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.